Axcelis Technologies, Inc. (NASDAQ:ACLS) Stock Has Average Price Target of $148.67 According to Analysts

Shares of Axcelis Technologies, Inc. (NASDAQ:ACLS) have been assigned a consensus rating of “Hold” from the five ratings firms that are covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the company. The average 1-year price target among brokers that have covered the stock in the last year is $148.67.

A number of research firms recently issued reports on ACLS. Weiss Ratings upgraded Axcelis Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, October 16th. Craig Hallum lowered shares of Axcelis Technologies from a “buy” rating to a “hold” rating and set a $140.00 target price for the company. in a report on Friday, August 7th.

Institutional Investors Weigh In On Axcelis Technologies

A number of institutional investors have recently added to or reduced their stakes in the stock. Public Employees Retirement System of Ohio purchased a new position in shares of Axcelis Technologies during the 2nd quarter worth $82,000. Ancora Advisors LLC acquired a new position in Axcelis Technologies in the second quarter valued at $95,000. NewEdge Advisors LLC raised its holdings in shares of Axcelis Technologies by 247.9% during the 2nd quarter. NewEdge Advisors LLC now owns 581 shares of the semiconductor company’s stock valued at $110,000 after buying an additional 414 shares during the period. MassMutual Private Wealth & Trust FSB raised its stake in shares of Axcelis Technologies by 25.9% in the 3rd quarter. MassMutual Private Wealth & Trust FSB now owns 598 shares of the semiconductor company’s stock valued at $78,000 after purchasing an additional 123 shares in the last quarter. Finally, Parallel Advisors LLC boosted its holdings in shares of Axcelis Technologies by 22.0% during the first quarter. Parallel Advisors LLC now owns 665 shares of the semiconductor company’s stock valued at $62,000 after acquiring an additional 120 shares during the period. Institutional investors and hedge funds own 89.98% of the company’s stock.

Axcelis Technologies Price Performance

Shares of NASDAQ ACLS opened at $100.07 on Friday. The company has a 50 day simple moving average of $118.51 and a 200 day simple moving average of $122.68. The company has a debt-to-equity ratio of 0.04, a current ratio of 4.90 and a quick ratio of 3.21. Axcelis Technologies has a 1 year low of $73.60 and a 1 year high of $193.78. The firm has a market cap of $3.09 billion, a PE ratio of 33.58, a price-to-earnings-growth ratio of 3.06 and a beta of 1.88.

Axcelis Technologies (NASDAQ:ACLS) last posted its quarterly earnings data on Thursday, August 6th. The semiconductor company reported $1.06 EPS for the quarter, topping analysts’ consensus estimates of $0.89 by $0.17. The company had revenue of $215.18 million for the quarter, compared to analyst estimates of $205.03 million. Axcelis Technologies had a return on equity of 11.69% and a net margin of 10.71%. The firm’s quarterly revenue was up 10.6% on a year-over-year basis. During the same period in the previous year, the firm earned $1.13 earnings per share. Axcelis Technologies has set its Q3 2026 guidance at 1.110-1.110 EPS. On average, research analysts forecast that Axcelis Technologies will post 3.39 EPS for the current year.

Axcelis Technologies Company Profile

Axcelis Technologies, Inc develops and manufactures equipment used in the fabrication of semiconductor devices. The company is best known for its ion implantation systems, which precisely introduce dopant atoms into silicon wafers to control the electrical properties of semiconductor components.

Its product portfolio includes the Purion family of ion implantation systems, designed for applications such as high-current, medium-current and high-energy implantation. Axcelis also provides related aftermarket products and services, including spare parts, equipment upgrades, process support and customer training.

Headquartered in Beverly, Massachusetts, Axcelis serves semiconductor manufacturers and other customers in major chip-production regions worldwide.